Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 159

    1.

    Positive anti-citrullinated protein antibody status and small joint arthritis are consistent predictors of chronic disease in patients with very early arthritis: results from the NOR-VEAC cohort.

    Mjaavatten MD, Uhlig T, Haugen AJ, Nygaard H, Sidenvall G, Helgetveit K, Kvien TK.

    Arthritis Res Ther. 2009;11(5):R146. Epub 2009 Oct 1.

    PMID:
    19796386
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    Databases of patients with early rheumatoid arthritis in the USA.

    Sokka T, Willoughby J, Yazici Y, Pincus T.

    Clin Exp Rheumatol. 2003 Sep-Oct;21(5 Suppl 31):S146-53. Review.

    PMID:
    14969067
    [PubMed - indexed for MEDLINE]
    3.

    Levels of anti-citrullinated protein antibodies and IgM rheumatoid factor are not associated with outcome in early arthritis patients: a cohort study.

    Ursum J, Bos WH, van Dillen N, Dijkmans BA, van Schaardenburg D.

    Arthritis Res Ther. 2010;12(1):R8. Epub 2010 Jan 12.

    PMID:
    20064278
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    4.

    Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage.

    Meyer O, Labarre C, Dougados M, Goupille P, Cantagrel A, Dubois A, Nicaise-Roland P, Sibilia J, Combe B.

    Ann Rheum Dis. 2003 Feb;62(2):120-6.

    PMID:
    12525380
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    5.

    Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study.

    van Gaalen FA, Linn-Rasker SP, van Venrooij WJ, de Jong BA, Breedveld FC, Verweij CL, Toes RE, Huizinga TW.

    Arthritis Rheum. 2004 Mar;50(3):709-15.

    PMID:
    15022309
    [PubMed - indexed for MEDLINE]
    Free Article
    6.

    Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.

    van der Linden MP, van der Woude D, Ioan-Facsinay A, Levarht EW, Stoeken-Rijsbergen G, Huizinga TW, Toes RE, van der Helm-van Mil AH.

    Arthritis Rheum. 2009 Aug;60(8):2232-41.

    PMID:
    19644872
    [PubMed - indexed for MEDLINE]
    Free Article
    7.

    Progression of joint damage in early rheumatoid arthritis: association with HLA-DRB1, rheumatoid factor, and anti-citrullinated protein antibodies in relation to different treatment strategies.

    de Vries-Bouwstra JK, Goekoop-Ruiterman YP, Verpoort KN, Schreuder GM, Ewals JA, Terwiel JP, Ronday HK, Kerstens PJ, Toes RE, de Vries RR, Breedveld FC, Dijkmans BA, Huizinga TW, Allaart CF.

    Arthritis Rheum. 2008 May;58(5):1293-8.

    PMID:
    18438829
    [PubMed - indexed for MEDLINE]
    Free Article
    8.

    Combining anti-cyclic citrullinated peptide with the American College of Rheumatology 1987 criteria failed to improve early rheumatoid arthritis diagnosis in the community-based very early arthritis cohort.

    Le Loët X, Strotz V, Lequerré T, Boumier P, Pouplin S, Mejjad O, Daragon A, Jouen F, Vittecoq O, Fardellone P, Ménard JF.

    Rheumatology (Oxford). 2011 Oct;50(10):1901-7. Epub 2011 Jul 12.

    PMID:
    21750000
    [PubMed - indexed for MEDLINE]
    9.

    Development of a scoring system for assessment of outcome of early undifferentiated inflammatory synovitis.

    El Miedany Y, Youssef S, Mehanna AN, El Gaafary M.

    Joint Bone Spine. 2008 Mar;75(2):155-62. Epub 2007 Sep 20.

    PMID:
    17980637
    [PubMed - indexed for MEDLINE]
    10.

    Therapeutic strategies in rheumatoid arthritis over a 40-year period.

    Kremers HM, Nicola P, Crowson CS, O'Fallon WM, Gabriel SE.

    J Rheumatol. 2004 Dec;31(12):2366-73.

    PMID:
    15570636
    [PubMed - indexed for MEDLINE]
    11.

    Contemporary use of disease-modifying drugs in the management of patients with early rheumatoid arthritis in Norway.

    Nikolaisen C, Kvien TK, Mikkelsen K, Kaufmann C, Rødevand E, Nossent JC.

    Scand J Rheumatol. 2009;38(4):240-5.

    PMID:
    19229766
    [PubMed - indexed for MEDLINE]
    12.

    Autoantibodies in early seropositive rheumatoid arthritis, before and during disease modifying antirheumatic drug treatment.

    Paulus HE, Wiesner J, Bulpitt KJ, Patnaik M, Law J, Park GS, Wong WK.

    J Rheumatol. 2002 Dec;29(12):2513-20.

    PMID:
    12465144
    [PubMed - indexed for MEDLINE]
    13.

    Anti-Sa antibodies and antibodies against cyclic citrullinated peptide are not equivalent as predictors of severe outcomes in patients with recent-onset polyarthritis.

    Boire G, Cossette P, de Brum-Fernandes AJ, Liang P, Niyonsenga T, Zhou ZJ, Carrier N, Daniel C, Ménard HA.

    Arthritis Res Ther. 2005;7(3):R592-603. Epub 2005 Mar 17.

    PMID:
    15899046
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    14.

    High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study.

    Syversen SW, Gaarder PI, Goll GL, Ødegård S, Haavardsholm EA, Mowinckel P, van der Heijde D, Landewé R, Kvien TK.

    Ann Rheum Dis. 2008 Feb;67(2):212-7. Epub 2007 May 25.

    PMID:
    17526555
    [PubMed - indexed for MEDLINE]
    15.

    Is rheumatoid factor still a superior test for the diagnosis of rheumatoid arthritis?

    Singh U, Vishwanath A, Verma PK, Singh NK, Shukla RC, Singh S, Singh S, Sonkar GK.

    Rheumatol Int. 2010 Jun;30(8):1115-9. Epub 2010 Jan 8.

    PMID:
    20058015
    [PubMed - indexed for MEDLINE]
    16.

    Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis.

    van der Helm-van Mil AH, Verpoort KN, Breedveld FC, Toes RE, Huizinga TW.

    Arthritis Res Ther. 2005;7(5):R949-58. Epub 2005 Jun 14.

    PMID:
    16207336
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    17.

    Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of disease.

    Machold KP, Stamm TA, Nell VP, Pflugbeil S, Aletaha D, Steiner G, Uffmann M, Smolen JS.

    Rheumatology (Oxford). 2007 Feb;46(2):342-9. Epub 2006 Aug 9.

    PMID:
    16899498
    [PubMed - indexed for MEDLINE]
    Free Article
    18.

    Serial determination of cyclic citrullinated peptide autoantibodies predicted five-year radiological outcomes in a prospective cohort of patients with early rheumatoid arthritis.

    Meyer O, Nicaise-Roland P, Santos MD, Labarre C, Dougados M, Goupille P, Cantagrel A, Sibilia J, Combe B.

    Arthritis Res Ther. 2006;8(2):R40. Epub 2006 Jan 26.

    PMID:
    16469118
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    19.

    Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: results from two large early arthritis cohorts.

    van der Woude D, Young A, Jayakumar K, Mertens BJ, Toes RE, van der Heijde D, Huizinga TW, van der Helm-van Mil AH.

    Arthritis Rheum. 2009 Aug;60(8):2262-71.

    PMID:
    19644846
    [PubMed - indexed for MEDLINE]
    Free Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk